Lotus Clinical Research is proud to be featured in an exciting study in collaboration with Evolution Research Group and Gonzaba Medical Group, exploring the cognitive effects of GLP-1 agonists in patients with type 2 diabetes and obesity. This study aims to uncover potential neuroprotective benefits and address health disparities in cognitive outcomes. Stay tuned for more updates as we advance scientific knowledge and improve patient outcomes!

Read the full press release here: Pioneering Insights: ERG, Lotus, and GMG Unveil Study on the potential impact of GLP-1 Agonists and Cognitive Health in Diabetes and Obesity